Focus Group Research with Physicians Regarding Drug Risk/Benefit Analysis in Variations of Display Pages of Print Direct-to-Consumer Prescription Drug Advertisements

Focus Groups as Used by the Food and Drug Administration

⚠️ Notice: This information collection may be referencing outdated material. More recent filings for OMB 0910-0497 can be found here:

Documents and Forms

Document Name Document Type
DTC Rx drug ads focus group MODERATOR GUIDE AND SCREENER 8-19-2008.doc Other-Focus Group Moderator Guide an

Information Collection (IC) Details

IC Title:	Focus Group Research with Physicians Regarding Drug Risk/Benefit Analysis in Variations of Display Pages of Print Direct-to-Consumer Prescription Drug Advertisements	Agency IC Tracking Number:

IC Status: New

Obligation to Respond: Voluntary

CFR Citation: 21 CFR 372

Information Collection Instruments:

Document Type	Form No.	Form Name	Instrument File	URL	Available Electronically?	Can Be Submitted Electronically?	Electronic Capability
Other-Focus Group Moderator Guide and Screener			DTC Rx drug ads focus group MODERATOR GUIDE AND SCREENER 8-19-2008.doc		No	No	Paper Only

Line of Business: Health

Subfunction: Consumer Health and Safety

Privacy Act System of Records
Title:	FR Citation:

Number of Respondents: 40	Number of Respondents for Small Entity: 0

Affected Public: Private Sector	Private Sector: Businesses or other for-profits

Percentage of Respondents Reporting Electronically: 0 %

	Approved	Program Change Due to New Statute	Program Change Due to Agency Discretion	Change Due to Adjustment in Agency Estimate	Change Due to Potential Violation of the PRA	Previously Approved
Annual Number of Responses for this IC	40	0	0	0	0	0
Annual IC Time Burden (Hours)	30	0	0	0	0	0
Annual IC Cost Burden (Dollars)	0	0	0	0	0	0

Documents for IC

Title	Document	Date Uploaded
No associated records found

Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.